Skip to main content

and
  1. No Access

    Article

    CN3OP: an active regimen in patients with relapsed/refractory Hodgkin's lymphoma

    Patients with recurrent or refractory Hodgkin's and non-Hodgkin's lymphoma are increasingly being treated with high-dose therapy and hematopoietic cell transplantation. As minimal disease status at the time of...

    J Walewski, JB Krzyżanowska, E Kraszewska, E Lampka in Medical Oncology (2000)